Enact (ACT) Proxy filing summary

Executive summary

• Achieved strong 2025 performance: $674M net income, $52B new insurance written, and record $273B insurance in-force.

• Returned over $500M to shareholders via dividends and share repurchases in 2025; total returns since IPO exceed $1.6B.

• Maintained robust capital and liquidity, with PMIERs sufficiency at $1.9B (162% of requirements) at year-end.

• Advanced strategic priorities: innovation in risk/pricing (Rate360), disciplined expense management, and expanded financial flexibility.

• Board and management express confidence in continued execution and value creation for shareholders.

Voting matters and shareholder proposals

• Election of eleven directors to serve until the 2027 Annual Meeting.

• Advisory vote to approve named executive officer compensation (say-on-pay).

• Ratification of KPMG LLP as independent registered public accounting firm for 2026.

• Board recommends voting FOR all proposals.

Board of directors and corporate governance

• Eleven director nominees, eight of whom are independent; diverse in gender, ethnicity, and experience.

• Board committees: Audit, Compensation, Nominating & Corporate Governance, Independent Capital, and Risk.

• Annual board and committee self-evaluations; all directors attended at least 75% of meetings.

• Governance best practices: annual director elections, special meeting rights, no poison pill, anti-hedging/pledging, and robust disclosure policies.

• Board leadership split between independent Chairperson and CEO.